These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15161658

  • 1. Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma.
    Rassidakis GZ, Lai R, Herling M, Cromwell C, Schmitt-Graeff A, Medeiros LJ.
    Am J Pathol; 2004 Jun; 164(6):2259-67. PubMed ID: 15161658
    [Abstract] [Full Text] [Related]

  • 2. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
    Oyarzo MP, Drakos E, Atwell C, Amin HM, Medeiros LJ, Rassidakis GZ.
    Hum Pathol; 2006 Jul; 37(7):874-82. PubMed ID: 16784988
    [Abstract] [Full Text] [Related]

  • 3. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
    Khoury JD, Medeiros LJ, Rassidakis GZ, Yared MA, Tsioli P, Leventaki V, Schmitt-Graeff A, Herling M, Amin HM, Lai R.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3692-9. PubMed ID: 14506160
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
    Rassidakis GZ, Sarris AH, Herling M, Ford RJ, Cabanillas F, McDonnell TJ, Medeiros LJ.
    Am J Pathol; 2001 Aug 01; 159(2):527-35. PubMed ID: 11485911
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma.
    Dalton RR, Rassidakis GZ, Atwell C, Wang S, Oyarzo MP, Medeiros LJ.
    Hum Pathol; 2005 Jul 01; 36(7):806-11. PubMed ID: 16084951
    [Abstract] [Full Text] [Related]

  • 6. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Lai R, Rassidakis GZ, Medeiros LJ, Ramdas L, Goy AH, Cutler C, Fujio Y, Kunisada K, Amin HM, Gilles F.
    Am J Pathol; 2004 Jun 01; 164(6):2251-8. PubMed ID: 15161657
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
    Rassidakis GZ, Goy A, Medeiros LJ, Jiang Y, Thomaides A, Remache Y, Cabanillas F, Sarris AH, Gilles F.
    Clin Cancer Res; 2003 Jun 01; 9(6):2213-20. PubMed ID: 12796388
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
    Amin HM, McDonnell TJ, Ma Y, Lin Q, Fujio Y, Kunisada K, Leventaki V, Das P, Rassidakis GZ, Cutler C, Medeiros LJ, Lai R.
    Oncogene; 2004 Jul 15; 23(32):5426-34. PubMed ID: 15184887
    [Abstract] [Full Text] [Related]

  • 9. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
    Hübinger G, Müller E, Scheffrahn I, Schneider C, Hildt E, Singer BB, Sigg I, Graf J, Bergmann L.
    Oncogene; 2001 Feb 01; 20(5):590-8. PubMed ID: 11313991
    [Abstract] [Full Text] [Related]

  • 10. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells.
    Rust R, Blokzijl T, Harms G, Lim M, Visser L, Kamps WA, Poppema S, van den Berg A.
    J Pathol; 2005 Aug 01; 206(4):445-50. PubMed ID: 15920698
    [Abstract] [Full Text] [Related]

  • 11. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
    Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ.
    J Clin Oncol; 2004 May 01; 22(9):1682-8. PubMed ID: 15117990
    [Abstract] [Full Text] [Related]

  • 12. High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma.
    Rust R, Visser L, van der Leij J, Harms G, Blokzijl T, Deloulme JC, van der Vlies P, Kamps W, Kok K, Lim M, Poppema S, van den Berg A.
    Br J Haematol; 2005 Dec 01; 131(5):596-608. PubMed ID: 16351635
    [Abstract] [Full Text] [Related]

  • 13. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW.
    Am J Surg Pathol; 2008 Sep 01; 32(9):1421-6. PubMed ID: 18670345
    [Abstract] [Full Text] [Related]

  • 14. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY, Johnston PB, Burke KA, Zhao Y.
    Cancer Res; 2006 Sep 15; 66(18):9002-8. PubMed ID: 16982741
    [Abstract] [Full Text] [Related]

  • 15. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
    Salaverria I, Beà S, Lopez-Guillermo A, Lespinet V, Pinyol M, Burkhardt B, Lamant L, Zettl A, Horsman D, Gascoyne R, Ott G, Siebert R, Delsol G, Campo E.
    Br J Haematol; 2008 Mar 15; 140(5):516-26. PubMed ID: 18275429
    [Abstract] [Full Text] [Related]

  • 16. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
    Sjostrom C, Seiler C, Crockett DK, Tripp SR, Elenitoba Johnson KS, Lim MS.
    Exp Hematol; 2007 Aug 15; 35(8):1240-8. PubMed ID: 17560012
    [Abstract] [Full Text] [Related]

  • 17. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
    Rassidakis GZ, Jones D, Lai R, Ramalingam P, Sarris AH, McDonnell TJ, Medeiros LJ.
    J Pathol; 2003 Jun 15; 200(2):240-8. PubMed ID: 12754745
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY, Zhao Y, Anderson WF, Johnston PB.
    Cancer Invest; 2007 Jun 15; 25(4):240-8. PubMed ID: 17612934
    [Abstract] [Full Text] [Related]

  • 19. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.
    Mehrotra M, Medeiros LJ, Luthra R, Sargent RL, Yao H, Barkoh BA, Singh R, Patel KP.
    Hum Pathol; 2014 Oct 15; 45(10):1995-2005. PubMed ID: 25128227
    [Abstract] [Full Text] [Related]

  • 20. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.
    Rassidakis GZ, Thomaides A, Wang S, Jiang Y, Fourtouna A, Lai R, Medeiros LJ.
    Leukemia; 2005 Sep 15; 19(9):1663-9. PubMed ID: 15990866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.